RNGTT and breast cancer: Interestingly, both glycosylated and unglycosylated hCE were observed in vivo (e.g. in breast cancer cell lines or cystatin E–overexpressing HEK293 cells), suggesting different (pathophysiological) functions for both variants (10, 20, 37).